Burcon Stock Today

BRCN
 Stock
  

USD 0.68  0.01  1.45%   

Market Performance
1 of 100
Odds Of Distress
Over 61
Burcon Nutrascience is selling for 0.68 as of the 14th of August 2022. This is a -1.45 percent decrease since the beginning of the trading day. The stock's open price was 0.69. Burcon Nutrascience has more than 61 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Burcon Nutrascience are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of June 2022 and ending today, the 14th of August 2022. Please note, there could be an existing legal relationship between Burcon Nutrascience (BRCN) and Burford Capital (BUR). Click here to learn more.
Fiscal Year End
March
IPO Date
27th of October 2011
Category
Consumer Defensive
ISIN
CA1208311029
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company was incorporated in 1998 and is headquartered in Vancouver, Canada. Burcon Nutrascience operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. The company has 108.66 M outstanding shares of which 127.14 K shares are currently shorted by private and institutional investors with about 2.39 trading days to cover. More on Burcon Nutrascience

Burcon Nutrascience Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Burcon Nutrascience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Burcon Nutrascience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Burcon Nutrascience has very high historical volatility over the last 90 days
Burcon Nutrascience has some characteristics of a very speculative penny stock
Burcon Nutrascience has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 171.47 K. Net Loss for the year was (10.26 M) with loss before overhead, payroll, taxes, and interest of (1.28 M).
Burcon Nutrascience currently holds about 7 M in cash with (5.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Burcon Nutrascience has a frail financial position based on the latest SEC disclosures
Roughly 24.0% of the company shares are held by company insiders
Latest headline from www.marketscreener.com: Burcon NutraScience Announces Fiscal 2023 First Quarter Conference Call to beHeld on August 15, 2022 - Form 6-K - Marketscreener.com
Related EntityBUR (Burford Capital)
Thematic IdeaFood Products (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Burcon Nutrascience report their recommendations after researching Burcon Nutrascience's financial statements, talking to executives and customers, or listening in on Burcon Nutrascience's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Burcon Nutrascience. The Burcon consensus assessment is calculated by taking the average forecast from all of the analysts covering Burcon Nutrascience.
Strong Buy1 Opinion
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Burcon Nutrascience based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Burcon Nutrascience financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares117 M108.4 M
Significantly Up
Increasing
Slightly volatile
Total Assets23.9 M29.3 M
Significantly Down
Increasing
Slightly volatile
Total Liabilities1.1 M1.1 M
Fairly Up
Increasing
Slightly volatile
Current Assets7.8 M7.6 M
Fairly Up
Increasing
Slightly volatile
Current Liabilities1.3 MM
Significantly Up
Increasing
Stable
Total Debt75.1 K73.1 K
Fairly Up
Increasing
Very volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.00670.005
Significantly Up
Decreasing
Very volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Burcon Nutrascience's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Burcon Nutrascience's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Burcon Nutrascience's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Burcon Nutrascience's financial leverage. It provides some insight into what part of Burcon Nutrascience's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Burcon Nutrascience's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Burcon Nutrascience deploys its capital and how much of that capital is borrowed.
Liquidity
Burcon Nutrascience cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 73.14 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Burcon Nutrascience has a current ratio of 7.15, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Burcon Nutrascience until it has trouble settling it off, either with new capital or with free cash flow. So, Burcon Nutrascience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Burcon Nutrascience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Burcon to invest in growth at high rates of return. When we think about Burcon Nutrascience's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(6.38 Million)
Burcon Nutrascience (BRCN) is traded on NASDAQ Exchange in USA. It is located in 1946 West Broadway and employs 26 people. Burcon Nutrascience is listed under Food Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 76.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Burcon Nutrascience's market, we take the total number of its shares issued and multiply it by Burcon Nutrascience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Burcon Nutrascience conducts business under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 108.66 M outstanding shares of which 127.14 K shares are currently shorted by private and institutional investors with about 2.39 trading days to cover. Burcon Nutrascience currently holds about 7 M in cash with (5.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Burcon Nutrascience Probability Of Bankruptcy
Ownership
Burcon Nutrascience holds a total of one hundred eight million six hundred sixty thousand outstanding shares. Burcon Nutrascience retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Burcon Ownership Details

Burcon Stock Price Odds Analysis

What are Burcon Nutrascience's target price odds to finish over the current price? Proceeding from a normal probability distribution, the odds of Burcon Nutrascience jumping above the current price in 90 days from now is about 13.77%. The Burcon Nutrascience probability density function shows the probability of Burcon Nutrascience stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Burcon Nutrascience has a beta of 0.511 suggesting as returns on the market go up, Burcon Nutrascience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Burcon Nutrascience will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2445, implying that it can generate a 0.24 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 0.68HorizonTargetOdds Above 0.68
86.18%90 days
 0.68 
13.77%
Based on a normal probability distribution, the odds of Burcon Nutrascience to move above the current price in 90 days from now is about 13.77 (This Burcon Nutrascience probability density function shows the probability of Burcon Stock to fall within a particular range of prices over 90 days) .

Burcon Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Burcon Nutrascience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Burcon Nutrascience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Burcon Nutrascience's value.
InstituionSecurity TypeTotal SharesValue
Awm Investment Company IncCommon Shares3.9 M1.5 M
Allianz Asset Management GmbhCommon Shares620.8 K245 K
View Burcon Nutrascience Diagnostics

Burcon Nutrascience Historical Income Statement

Burcon Nutrascience Income Statement is one of the three primary financial statements used for reporting Burcon's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Burcon Nutrascience revenue and expense. Burcon Nutrascience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Burcon Nutrascience Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 74,435.61. Weighted Average Shares is expected to rise to about 117 M this year, although the value of Consolidated Income will most likely fall to (11.1 M). View More Fundamentals

Burcon Stock Against Markets

Picking the right benchmark for Burcon Nutrascience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Burcon Nutrascience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Burcon Nutrascience is critical whether you are bullish or bearish towards Burcon Nutrascience at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Burcon Nutrascience without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Invested in Burcon Nutrascience?

You need to understand the risk of investing before taking a position in Burcon Nutrascience. The danger of trading Burcon Nutrascience is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Burcon Nutrascience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Burcon Nutrascience. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Burcon Nutrascience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Burcon Nutrascience information on this page should be used as a complementary analysis to other Burcon Nutrascience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Burcon Stock analysis

When running Burcon Nutrascience price analysis, check to measure Burcon Nutrascience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burcon Nutrascience is operating at the current time. Most of Burcon Nutrascience's value examination focuses on studying past and present price action to predict the probability of Burcon Nutrascience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Burcon Nutrascience's price. Additionally, you may evaluate how the addition of Burcon Nutrascience to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is Burcon Nutrascience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Burcon Nutrascience. If investors know Burcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Burcon Nutrascience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
74.9 M
Quarterly Revenue Growth YOY
-0.69
Return On Assets
-0.14
Return On Equity
-0.32
The market value of Burcon Nutrascience is measured differently than its book value, which is the value of Burcon that is recorded on the company's balance sheet. Investors also form their own opinion of Burcon Nutrascience's value that differs from its market value or its book value, called intrinsic value, which is Burcon Nutrascience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Burcon Nutrascience's market value can be influenced by many factors that don't directly affect Burcon Nutrascience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Burcon Nutrascience's value and its price as these two are different measures arrived at by different means. Investors typically determine Burcon Nutrascience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Burcon Nutrascience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.